Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus
View ORCID ProfileLydia Zorn-Pauly, View ORCID ProfileAnne Sae Lim von Stuckrad, View ORCID ProfileJens Klotsche, View ORCID ProfileThomas Rose, View ORCID ProfileTilmann Kallinich, View ORCID ProfilePhilipp Enghard, View ORCID ProfileLennard Ostendorf, View ORCID ProfileMarie Burns, View ORCID ProfileThomas Doerner, View ORCID ProfileChristian Meisel, View ORCID ProfileUdo Schneider, Nadine Unterwalder, View ORCID ProfileGerd Burmester, View ORCID ProfileFalk Hiepe, View ORCID ProfileTobias Alexander, View ORCID ProfileRobert Biesen
doi: https://doi.org/10.1101/2021.09.25.21263771
Lydia Zorn-Pauly
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Anne Sae Lim von Stuckrad
2Pediatric Pneumology, Immunology and Intensive Care Medicine, Charité University Medicine Berlin, Berlin, Germany
Jens Klotsche
3German Rheumatism Research Center Berlin – a Leibniz Institute (DRFZ), Berlin, Germany
Thomas Rose
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Tilmann Kallinich
2Pediatric Pneumology, Immunology and Intensive Care Medicine, Charité University Medicine Berlin, Berlin, Germany
3German Rheumatism Research Center Berlin – a Leibniz Institute (DRFZ), Berlin, Germany
Philipp Enghard
4Department of Nephrology and Intensive Care Medicine, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
Lennard Ostendorf
3German Rheumatism Research Center Berlin – a Leibniz Institute (DRFZ), Berlin, Germany
4Department of Nephrology and Intensive Care Medicine, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
Marie Burns
3German Rheumatism Research Center Berlin – a Leibniz Institute (DRFZ), Berlin, Germany
Thomas Doerner
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Christian Meisel
5Institute for Medical Immunology, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
Udo Schneider
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Nadine Unterwalder
5Institute for Medical Immunology, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
Gerd Burmester
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Falk Hiepe
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Tobias Alexander
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
3German Rheumatism Research Center Berlin – a Leibniz Institute (DRFZ), Berlin, Germany
Robert Biesen
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Data Availability
Data are available on reasonable request. All data relevant to the study are included in the article or uploaded as online supplemental information. All source data including but not limited to scoring results and primary imaging are available from the corresponding author on request.
Posted September 27, 2021.
Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus
Lydia Zorn-Pauly, Anne Sae Lim von Stuckrad, Jens Klotsche, Thomas Rose, Tilmann Kallinich, Philipp Enghard, Lennard Ostendorf, Marie Burns, Thomas Doerner, Christian Meisel, Udo Schneider, Nadine Unterwalder, Gerd Burmester, Falk Hiepe, Tobias Alexander, Robert Biesen
medRxiv 2021.09.25.21263771; doi: https://doi.org/10.1101/2021.09.25.21263771
Evaluation of SIGLEC1 in the diagnosis of suspected systemic lupus erythematosus
Lydia Zorn-Pauly, Anne Sae Lim von Stuckrad, Jens Klotsche, Thomas Rose, Tilmann Kallinich, Philipp Enghard, Lennard Ostendorf, Marie Burns, Thomas Doerner, Christian Meisel, Udo Schneider, Nadine Unterwalder, Gerd Burmester, Falk Hiepe, Tobias Alexander, Robert Biesen
medRxiv 2021.09.25.21263771; doi: https://doi.org/10.1101/2021.09.25.21263771
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)